Taro Pharmaceutical Industries Ltd
F:TAL
Taro Pharmaceutical Industries Ltd
F:TAL
Price:
40
EUR
1.01%
Market Closed
Market Cap:
€1.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Taro Pharmaceutical Industries Ltd
F:TAL
|
IL |
|
Intega Group Ltd
ASX:ITG
|
AU |
|
Whitehaven Coal Ltd
ASX:WHC
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of TAL.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TAL
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
TAL Competitors Multiples
Taro Pharmaceutical Industries Ltd Competitors
Taro Pharmaceutical Industries Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
|
Taro Pharmaceutical Industries Ltd
F:TAL
|
1.5B EUR | 2.8 | 32.9 | 16.9 | 41.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
901.8B USD | 13.8 | 43.7 | 29.5 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD | 2.6 | 20.9 | 7.9 | 10.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
